24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Monday's big drop because they have some aspect of their business that might be immune to…
Monday's top analyst upgrades, downgrades and initiations included American Express, ADT, Gilead Sciences, Logitech, PACCAR, Regions Financial, Stamps.com and Vivint Smart Home.
These 10 stocks have incredibly strong stock charts and strong performance despite the crummy market conditions that have been seen so far in 2020.
Tuesday's top analyst upgrades, downgrades and initiations included Apple, Baker Hughes, BHP, Gilead Sciences, Microsoft, PG&E, Schlumberger, Shopify, Tesla, Uber Technologies, UPS, Vale and YETI.
Forty Seven shares skyrocketed on Monday after the company announced that it would be acquired by Gilead Sciences. But is Gildead paying too much?
Chris Lange These stocks that are either defensive in general or are defying the big drop because they have some aspect of their business that might be immune to daily scares or because they…
Friday's top analyst upgrades, downgrades and initiations included Beyond Meat, CBOE, Chesapeake Energy, Dollar General, FLIR Systems, Gilead Sciences, Lyft, Novavax, RBS, Uber and Zoom Video Communications.
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems and Virgin Galactic.
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Day two of the coronavirus scare is now in the books and practically all major American averages are down over 3% for their second consecutive day. Currently all the gains for the…
24/7 Wall St. has tracked some of the stocks that are either defensive in general or that are defying Monday's big drop in the markets.
Gilead Sciences stock surged while the broader market was battered on reports that a senior official from the World Health Organization said that Gilead's remdesivir may currently be the best bet on…
Jon C. Ogg The broad markets are getting crushed on Monday on renewed fears of the spread of the coronavirus (Covid-19). But a handful of stocks were acting as a natural hedge to the virus…
With more than 60,000 reported cases of the coronavirus and nearly 1,400 deaths worldwide along with quarantines and travel restrictions, the impact of the disease on global GDP is just beginning to…
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
